Reneo Pharmaceuticals (RPHM) Earnings Date, Estimates & Call Transcripts $1.52 +0.02 (+1.07%) (As of 10:52 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 7) -$0.25 Beat By $0.12 Consensus EPS (May. 7) -$0.37 Get Reneo Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RPHM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRPHM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RPHM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Financial Markets DailyNYSE biotech company's drug could be as revolutionary as penicillin!NV-387 could be a single drug to treat all of the "tripledemic" viruses and more! See how NV-387 could be highly valuable for preparedness against novel viral epidemics and pandemics all while building shareholder value for this growing biotech companyClick here for the company ticker Reneo Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.59)($0.58)($0.59)Q2 20243($0.65)($0.22)($0.48)Q3 20243($0.73)($0.19)($0.51)Q4 20243($0.81)($0.17)($0.55)FY 202411($2.78)($1.16)($2.13)RPHM Earnings Date and InformationReneo Pharmaceuticals last issued its quarterly earnings data on May 7th, 2024. The reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.12. Reneo Pharmaceuticals has generated ($2.17) earnings per share over the last year (($2.17) diluted earnings per share). Earnings for Reneo Pharmaceuticals are expected to grow in the coming year, from ($0.83) to ($0.38) per share. Reneo Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Reneo Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/7/2024Q1 2024($0.37)($0.25)+$0.12($0.25)--3/28/2024Q4 2023($0.55)($0.70)($0.15)($0.70)--11/13/2023Q3 2023($0.60)($0.57)+$0.03($0.57)--8/10/2023Q2 2023($0.55)($0.65)($0.10)($0.65)--5/11/2023Q1 2023($0.63)($0.60)+$0.03($0.60)--3/27/2023Q4 2022($0.59)($0.56)+$0.03($0.56)-- Get the Latest News and Ratings for RPHM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($0.58)($0.53)+$0.05($0.53)--8/9/2022Q2 2022($0.60)($0.50)+$0.10($0.50)--5/10/2022Q1 2022($0.54)($0.53)+$0.01($0.53)--3/23/2022Q4 2021($0.59)($0.43)+$0.16($0.43)--11/11/2021Q3 2021($0.47)($0.52)($0.05)($0.52)--8/11/2021Q2 2021($0.37)($0.43)($0.06)($0.43)--5/19/2021Q1 2021($0.38)($3.48)($3.10)($3.48)-- Reneo Pharmaceuticals Earnings - Frequently Asked Questions When is Reneo Pharmaceuticals's earnings date? Reneo Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on RPHM's earnings history. Did Reneo Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Reneo Pharmaceuticals (NASDAQ:RPHM) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.12. Learn more on analysts' earnings estimate vs. RPHM's actual earnings. How much profit does Reneo Pharmaceuticals generate each year? Reneo Pharmaceuticals (NASDAQ:RPHM) has a recorded net income of -$77.39 million. RPHM has generated -$2.17 earnings per share over the last four quarters. What is Reneo Pharmaceuticals's EPS forecast for next year? Reneo Pharmaceuticals's earnings are expected to grow from ($0.83) per share to ($0.38) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Milestone Pharmaceuticals Earnings Citius Pharmaceuticals Earnings Q32 Bio Earnings Akebia Therapeutics Earnings Eliem Therapeutics Earnings Trevi Therapeutics Earnings Prelude Therapeutics Earnings 23andMe Earnings Zevra Therapeutics Earnings Gossamer Bio Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Analysts and Earnings Propel the S&P 500's Continuous GrowthBlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings Drop This page (NASDAQ:RPHM) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredNYSE biotech company's drug could be as revolutionary as penicillin!NV-387 could be a single drug to treat all of the "tripledemic" viruses and more! See how NV-387 could be h...Financial Markets Daily | Sponsored50-year Wall Street Legend: “Prepare for a cash avalanche”The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the star...Chaikin Analytics | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reneo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.